Application 212435
- Type
- ANDA
- Sponsor
- GLAND PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METRONIDAZOLE IN PLASTIC CONTAINER | METRONIDAZOLE | INJECTABLE;INJECTION | 500MG/100ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212435-001 | METRONIDAZOLE IN PLASTIC CONTAINER | METRONIDAZOLE | 500MG/100ML | INJECTABLE / INJECTION | AP | 2020-08-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212435-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212435-001 | METRONIDAZOLE IN PLASTIC CONTAINER | 500MG/100ML | INJECTABLE / INJECTION | AP | 2020-08-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212435-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METRONIDAZOLE | METRONIDAZOLE | Sun Pharmaceutical Industries, Inc. | 7187779a-1f4c-4607-af53-4119e324aad5 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 212435 ANDA212435 47335-993 |
| Metronidazole | METRONIDAZOLE | Gland Pharma Limited | 74cf111a-9b83-4f93-b0e8-bc252d471d43 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 212435 ANDA212435 68083-373 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47335-993 | METRONIDAZOLE | metronidazole | Sun Pharmaceutical Industries, Inc. | ANDA | Current |
| 47335-993 | METRONIDAZOLE | metronidazole | Sun Pharmaceutical Industries, Inc. | ANDA | Current |
| 68083-373 | Metronidazole | Metronidazole | Gland Pharma Limited | ANDA | Current |
| 68083-373 | Metronidazole | Metronidazole | Gland Pharma Limited | ANDA | Current |
| 68083-373 | Metronidazole | Metronidazole | Gland Pharma Limited | ANDA | Current |
| 68083-373 | Metronidazole | Metronidazole | Gland Pharma Limited | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64393 | ORIG | 2020-08-24 |